Letter to the editor
Bernhard Ralla, Christoph Holtmann, Gerd Geerling
Department of Ophthalmology, University of Düsseldorf, Düsseldorf, Germany
It is with great interest that we read the publication by Kanellopoulos.1 In this the author shows in a group of 21 patients with 46 months of mean follow-up that the new CXL protocol described, where higher fluence UV light is used with shorter exposure, appears to be a safe, comfortable and effective treatment for stabilizing a progressive keratoconus. This is a very valuable observation. The author also concludes, that collagen cross linking may be a promising adjunct treatment in cases, where a risk of post-LASIK-keratectasia is suspected. LASIK for correction of keratectasia is still controversially discussed. If used as a prophylactic treatment to prevent post-LASIK keratectasia, we would like to point out that the cross linking should be performed preferably after the LASIK procedure because the first will impact various steps of the refractive laser treatment.
View original paper by Kanellopoulos.
Erratum for this Letter to the Editor has been published
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]